Biotech News
Related news
HYPRHyperfine2026-11-19 21:30 EST
Hyperfine to Present at the Piper Sandler 38th Annual Healthcare Conference on December 3
PLSEPulse Biosciences2026-11-19 21:05 EST
Pulse Biosciences to Present at Piper Sandler 38th Annual Healthcare Conference
ICUIICU Medical2026-11-19 13:30 EST
ICU Medical to Participate at the Piper Sandler 38th Annual Healthcare Conference
LUNGPulmonx2026-11-18 21:05 EST
Pulmonx to Participate in the Piper Sandler 38th Annual Healthcare Conference
TCMDTactile Systems Technology, Inc.2026-11-18 21:05 EST
Tactile Medical to Participate in the Piper Sandler 38th Annual Healthcare Conference
CVRXCVRx2026-11-17 21:05 EST
CVRx to Participate at the Piper Sandler 38th Annual Healthcare Conference
ATRCAtriCure2026-11-17 13:00 EST
AtriCure to Participate in the Piper Sandler 38th Annual Healthcare Conference
ICUIICU Medical2026-11-06 13:30 EST
ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London
IARTIntegra LifeSciences2026-11-06 13:00 EST
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
TMCITreace Medical Concepts2026-11-03 21:05 EST
Treace to Present at the Stifel 2026 Healthcare Conference
RxSight
Adjustable Cataract Lenses RxSight is an ophthalmic medical-device company focused on customized vision after cataract surgery. Light Adjustable Lens System The system combines an implantable Light Adjustable Lens with a Light Delivery Device. After surgery, physicians use ultraviolet light treatments to modify the lens and refine the...
Recent company news
RXSTRxSight2026-11-19 21:05 EST
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
RXSTRxSight2026-11-03 21:05 EST
RxSight, Inc. Reports Third Quarter 2026 Results
RXSTRxSight2026-10-24 00:00 EST
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
RXSTRxSight2026-10-20 20:05 EST
RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3
RXSTRxSight2026-10-19 13:00 EST
RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
Stock data
- Close
- 4.61 USD
- Market cap
- 204.5M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States
